Leaflet URAPIDIL KALCEKS 25mg solution for injection / infusion

Product code:
W67799001
Quantity:
5
Indicated for:
hypertension
Route of administration:
injectable / infusion
Substance:
urapidil (antihypertensive)
ATC
C02CA06 — Cardiovascular system | Antiadrenergic agents, peripherally acting | Alpha-adrenoreceptor antagonists
Urapidil is a medication used in the treatment of hypertension, particularly in cases of hypertensive emergencies. It acts as an antagonist of alpha-1 adrenergic receptors and an agonist of serotonin 5-HT1A receptors, providing a rapid and controlled reduction in blood pressure.

Urapidil is administered intravenously in acute situations or orally for long-term hypertension management. The dosage and administration method are determined by the physician based on the severity of the condition and the patient's response to treatment.

Common side effects include dizziness, headache, nausea, and fatigue. In rare cases, allergic reactions or severe hypotension may occur. It is important to use urapidil under strict medical supervision, especially in patients with other cardiovascular conditions.

Urapidil is an effective medication for controlling hypertension, helping to reduce the risk of serious complications such as stroke or myocardial infarction.

General data about URAPIDIL KALCEKS 25mg

Substance:
urapidil
Date of latest medicines list:
01-06-2026
Product code:
W67799001
Concentration:
25mg
Pharmaceutical form:
solution for injection / infusion
Quantity:
5
Product type:
Generic medicine
Price:
66.47 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
AS KALCEKS - LETONIA
Holder:
AS KALCEKS - LETONIA
Number:
13831/2021/01
Shelf life:
2 years-after packing for marketing;dupa dilutie-it is used immediately

Concentrations available for urapidil

  • 100mg
  • 25mg
  • 25mg/5ml
  • 50mg
  • 50mg/10ml